Keyfactor raises $125M and merges with PrimeKey to create a machine identity management platform
21 Apr, 2021
– ClinSpec Diagnostics is a Glasgow, Scotland, UK-based developer of liquid biopsies for early detection of cancer.
– The company raised £3.5M in funding led by Norcliffe Capital Limited, the University of Strathclyde, Eos Advisory and the founders.
– The first tranche of the investment (£2.4M) was secured in 2020 led by Mercia’s EIS Funds with Scottish Enterprise, profit with purpose investor SIS Ventures, Eos Advisory and the University of Strathclyde.